glp-1 obesity cardiovascular news Bridging the gap between GLP1-receptor agonists and outcomes: evidence for the role of tirzepatide | Cardiovascular Diabetology Glucagon-like peptide 1 receptor agonists:

Same amount of medication

While the study did identify a slightly higher prevalence of gastrointestinal (GI) issues in the GLP-1RA group, the difference was not statistically significant

Tirzepatide in type 1 diabetes: single-centre observational cohort (N=26), 2025

[6] How often do you need labs

These supplements are designed to help address common nutritional considerations while taking GLP-1 medications, including protein intake, hydration, digestive support, and maintaining energy levels

It lists starting body weight among six factors it says govern speed, alongside diet quality, exercise consistency, titration, and baseline insulin resistance